Rule of 40 = 114, U.S. Commercial +121%, FY25 Raised Again — and the Stock Falls 8% on Burry Short and Valuation: Maintaining Hold

Results vs. Consensus

Q3 2025 was a broader and larger beat than Q2, on every line that matters. Revenue cleared Palantir's own guide by ~$96M (+8.8%) and the Street by ~$91M (+8.0%) — the second consecutive quarter where the magnitude of the beat exceeded every recent comparable. The acceleration in YoY growth (+63% vs. +48% in Q2) at $1.2B of quarterly revenue is statistically anomalous; this is the ninth consecutive quarter of accelerating top-line growth and the first time in company history Palantir has guided to sequential QoQ growth of 13% (Q4 25).

Quality of the Beat

• Revenue: Fully organic, no acquisitions, no FX-driven distortion. The $96M dollar beat over Palantir's own guide is the largest in absolute terms in the company's history. Notably, this is the second consecutive quarter where U.S. Commercial drove a disproportionate share of upside — segment revenue of $397M vs. the implicit $370M trajectory baked into the Aug guide raise contributes ~$27M of the $96M beat. The remainder is U.S. Government and International overshoots. Quality is unambiguous.
• Margins: The 500 bps adj OI margin beat (51% vs. 46% guide) is the cleanest piece of the print and signals a structurally different operating profile than what the August guide implied. Critically, this was supposed to be the quarter of "significant ramp in expenses … due to the seasonality of new hire starts" (per Glazer on the Q2 call). The fact that margins expanded 500 bps QoQ while hiring ramped is the strongest possible read on internal AI leverage. Sankar's "we've made our FTEs wildly more productive" comment is the qualitative version of an operating story that just became quantitative: revenue +63% YoY against headcount +~10% YoY is a productivity slope no large software peer is currently delivering.
• EPS: Adjusted EPS of $0.21 (+24% beat) is operationally driven, not below-the-line tax engineering. SBC expense relative to revenue continues to compress (broadly tracking the ~13% YoY pace flagged in Q2 against +63% revenue growth). Interest income on the ~$6.4B treasury portfolio remains a real but rate-dependent contributor; on the current Fed path that contribution will fade over the next 12 months. GAAP EPS of $0.18 implies roughly $0.72 GAAP run-rate, which is the right way to think about underlying earning power before adjustments — and at ~$190 still leaves the stock at ~265x trailing GAAP earnings.
• FCF: $540M of adj FCF on $1.181B of revenue is a 46% FCF margin — lower than Q2's 57% but still extraordinary. The QoQ moderation is largely working capital normalization (Q2 had been flattered by deferred revenue timing). FY25 adj FCF guide raised to $1.9–2.1B (+$100M @ midpoint vs. prior) implies H2 25 FCF of ~$1.0–1.2B against $887M H1 actual — well above prior trajectory.

Segment Performance

U.S. Commercial — The Reacceleration That Wasn't Supposed to Happen

U.S. Commercial revenue of $397M (+121% YoY, +29% QoQ) is the print that defines the quarter. To put the trajectory in context: U.S. Commercial grew +71% in Q1, +93% in Q2, and now +121% in Q3. We wrote in our Q2 note that the bear-case math required the rate to decelerate as the base scaled; instead, the rate accelerated again at a materially higher base. The leading indicators tell a self-reinforcing story: U.S. Commercial TCV bookings of $1.31B in the quarter alone (+342% YoY), U.S. Commercial RDV of $3.63B (+199% YoY, +30% sequentially), and 530 customers (+65% YoY) with 83 deals over $1M, 40 over $5M, and 21 over $10M just in the U.S. Commercial book. NDR jumped 600 bps QoQ to 134% — meaning existing customers are now expanding at a 34% net rate before counting new logos.

Ryan Taylor's framing on the call — that customers are no longer asking how to deploy AIP for one use case but how to roll it out across the entire enterprise within months — is the qualitative texture behind the leading indicators. The 6x increase in dollar-weighted contract duration vs. one year ago is the technical signal that what looks like booking acceleration is also a structural lengthening of revenue visibility. This is no longer a boot camp pipeline being converted incrementally; it's an enterprise-wide platform decision being made by the C-suite.

"We closed $1.3 billion in TCV. At 6x on a dollar-weighted duration basis from what it was a year ago." — Ryan Taylor, CRO

"Newer clients have much higher expectations of us … I wanna transform my business. I wanna do it in months." — Alex Karp, CEO

Assessment: The reacceleration to +121% materially derisks the U.S. Commercial growth trajectory through at least mid-2026. With $3.63B of segment RDV against $397M of in-quarter revenue, the contracted future revenue base is now ~9x in-quarter run rate — a coverage ratio that mathematically supports several more quarters of high-double-digit growth even on conservative conversion assumptions. The deceleration cliff that defined the Q2 bear case has not been eliminated, but it has been pushed at least one full quarter into the future, which matters enormously for the multi-year multiple support.

U.S. Government — Steady Anchor, Army EA Beginning to Show

U.S. Government revenue of $486M (+52% YoY, +14% QoQ) was largely in line with the Q2 +53% trajectory and represents the first quarter to include partial draw-down on the Army 10-year enterprise agreement announced over the summer. Sankar disclosed that the Army Vantage consolidation directive is now enabling broader internal AIFDE adoption among uniformed Army personnel — the operational mechanism by which the $10B ceiling translates into actual quarterly task-order revenue. The pace is consistent with a multi-year ramp rather than a one-quarter step function, which is the right shape for modeling the FY26–FY27 government trajectory.

Assessment: U.S. Government continues to function as the steady-Eddie compounder underwriting the volatility on the commercial side. The +52% growth at this scale is well above any defense-tech peer, and the structural derisk from the Army EA, Maven, NGC2, and Golden Dome program inclusion remains the binding constraint on the segment's downside. Modeling discipline still says: do not pull the $10B Army ceiling forward into any near-term forecast.

International — Europe Stagnant, Government Holding

The combined international book (~$298M, +9% QoQ) reflects continued bifurcation between international government (UK and broader European defense modernization, holding) and international commercial (which Sankar characterized in Q&A as "stagnant"). The strategic posture — deliberately deprioritized in favor of redirecting FDE capacity to the U.S. — is unchanged from Q2. The risk profile is also unchanged: at some point a credible re-engagement plan is required, otherwise European hyperscaler PaaS competitors lock in long-cycle commercial accounts that Palantir is forfeiting.

Assessment: A two-quarter pattern is now a three-quarter pattern. International commercial is a vulnerability that the magnitude of U.S. results is masking. Worth tracking but not a near-term concern given U.S. dominance.

Key KPIs

Every leading indicator inflected sharply higher again, on top of a Q2 print that was already historically anomalous. The combination of NDR at 134% (now 12 percentage points above Q1 25's 124%), $1.31B of single-quarter U.S. Commercial TCV, and 21 deals over $10M in U.S. Commercial alone is a leading-indicator picture that no software business at this scale has previously produced. The 51% adj operating margin against a ~10% YoY headcount growth rate is the operating-leverage proof point that justifies management's "AI on AI" framing of internal productivity.

Key Topics & Management Commentary

Overall Management Tone: Triumphant and combative, with the combative element notably more pronounced than Q2. Karp's prepared remarks repeatedly framed the print as historically best-in-class for the software industry; in interviews following the call, he characterized Burry's short position as "market manipulation" and "bats--t crazy." Sankar leaned into the "AI on AI" productivity story as the central operating proof point. Glazer's CFO commentary remained methodical and clean. The shift from Q2 vs. Q3 is a meaningful escalation of the CEO's combative posture — a positive read on conviction but a watch item for institutional sentiment.

1. The Operating Leverage Story Becomes the Story

The single most important shift in this print vs. Q2 is the elevation of operating leverage from "supporting fact" to "central narrative." Sankar's prepared remarks framed Palantir as the first large software company demonstrably running its own internal operations on AI: ~10% headcount growth driving 63% revenue growth and a 51% adj operating margin. The implication for the long-term P&L profile is large — if the productivity slope holds, the structural ceiling for adj operating margin moves from "high 40s" to "mid-to-high 50s." That is several hundred basis points of incremental fair-value support for the multiple.

"Our head count has grown roughly 10%, but revenue grew 63%. How are we doing that? We've made our FTEs wildly more productive." — Shyam Sankar, CTO

Assessment: If durable, this is the most important quantitative shift in the Palantir story since the AIP launch. We will treat one quarter as a signal but not a proof point; two more quarters of margin expansion at decelerating headcount growth would justify a structural reset of our long-term margin assumptions.

2. U.S. Commercial Reacceleration — Mechanism and Durability

The reacceleration from +93% to +121% in U.S. Commercial is mechanistically explained by the shift Taylor described: customers no longer buying single-use AIP licenses but enterprise-wide platform decisions made by the C-suite, with deal velocity collapsing from years to months. The 6x dollar-weighted duration multiple and the 21 U.S. Commercial deals over $10M are the technical evidence. The healthcare boot-camp $88M TCV deal we cited in Q2 is no longer the outlier — it is the new norm.

"You used to have to take your company private to change the unit economics of it … what we're doing actually in enterprises is providing a private equity-like transformation." — Alex Karp, CEO

Assessment: The reacceleration substantially derisks the +85% U.S. Commercial FY25 number embedded in management's guidance and pushes the deceleration question one full quarter further out. The next sustainability test is whether a +120%+ rate compounds against the harder Q4 25 / Q1 26 comp set. If the rate even stays in the +90–100% range against those comps, the multi-year story is durable.

3. Army EA Begins Translating Into Run-Rate Revenue

The U.S. Government segment grew +52% YoY with what we believe is the first material quarter of Army Vantage / EA-related task-order revenue. Sankar's framing — that the Army's consolidation directive is enabling broader AIFDE adoption among uniformed personnel — is the operational mechanism that converts the $10B ceiling into recurring quarterly revenue. The expected shape is a multi-quarter ramp rather than a step function, consistent with how prior DoD enterprise consolidations have typically translated into bookings.

Assessment: First evidence the Army EA is converting to revenue, but no quantification disclosed. We continue to model the Army contribution as a multi-quarter glide path, not a step function. The structural derisk effect on the FY26–FY30 government revenue line is what matters most; the in-quarter contribution is secondary.

4. AIFDE / Internal AI Leverage as a Customer-Replicable Product

Sankar's "two human FTEs spawned an army of AI FTEs" anecdote — a multi-year migration project completed in five days — is positioned not just as internal productivity but as a customer-replicable productivity story. If AIFDE-as-product is a credible secondary revenue lever (sold as a tooling layer alongside AIP), it expands the addressable wallet inside existing accounts. We did not see explicit dollar contribution disclosed for AIFDE-related revenue in Q3, but the strategic positioning is meaningfully more aggressive than in Q2.

Assessment: AIFDE has graduated from internal tool to externally messaged product. The next print should reveal whether it is also a discrete revenue contributor or remains a productivity-multiplier sold inside the AIP envelope. Either outcome is positive; clarity would help modeling.

5. Cultural Posture — Karp Goes on Offense

Karp's combative posture in prepared remarks and especially in post-print interviews on Nov 4 is a noticeable escalation from Q2. The "best results any software company has ever delivered" framing, coupled with explicit attacks on Burry's short position (and the market-manipulation accusation), shifts the company's PR posture from defensive-confident (Q2) to offensive-confrontational (Q3). For the bull case, this is read as conviction; for the bear case, it reads as defensiveness about valuation. The institutional shareholder base will tolerate this from a CEO printing 63% revenue growth and a Rule of 40 of 114; that tolerance has limits if growth ever normalizes.

Assessment: Tactically, going on offense against a high-profile short is a media win for the company and probably a marginal positive for retail sentiment. Strategically, it raises the bar for Q4: any in-line print after this rhetorical posture will be read as a deceleration. We would prefer a quieter posture but acknowledge the choice is consistent with Karp's brand.

6. What Did Not Get Discussed: Hyperscaler PaaS, International, FY26 Framing

The conspicuous omissions from the call are the same three from Q2: no direct engagement with the Microsoft Fabric / Databricks / Snowflake competitive question, no plan for international commercial reactivation, and no FY26 framing despite the magnitude of the FY25 raise. Sankar's "OWS / re-platforming" pitch from Q2 was reiterated implicitly through the customer anecdotes but not quantified. The continuing silence on FY26 was specifically called out by sell-side commentary in the post-print sessions and is one identifiable contributor to the Nov 4 sell-off.

Assessment: Omissions are consistent with Palantir's historical posture (FY+1 framing on Q4 calls), but at this multiple the market is increasingly impatient. The Q4 print in February will likely get more harsh treatment if FY26 framing is conservative or absent.

Guidance & Outlook

This is the second consecutive quarter of guide raises that materially exceed the magnitude of the in-quarter beat. The FY25 revenue raise of $252M at midpoint reflects approximately $96M of Q3 beat plus ~$156M of upside in Q4 (vs. previous Street ~$1.155B). The U.S. Commercial guide raise from ">$1.302B" to ">$1.433B" implies H2 25 U.S. Commercial of approximately $851M (vs. $582M H1 25 actual) — a ~46% sequential ramp that requires the +120% YoY rate to persist into Q4. Critically, the Q4 25 revenue guide of $1,329M midpoint requires +13% QoQ — the largest sequential growth Palantir has ever guided to and well above any historical seasonality pattern.

Implied Q4 mechanics: Revenue $1,329M midpoint represents +12.5% QoQ off Q3's $1,181M actual. The U.S. Commercial guide of >$1,433B on FY25 less Q1–Q3 25 actual of $1,037M (estimated $334M Q1 + $306M Q2 + $397M Q3) implies Q4 U.S. Commercial of >$396M — flat-to-up sequentially despite the typical Q4 commercial seasonality. The implication: management is signaling that the U.S. Commercial run rate is now structurally above $400M/quarter heading into 2026.

Street will likely reset to: FY25 revenue at the high end of the new range (~$4.4B) and FY26 to ~$6.4–6.7B (vs. ~$5.7–6.0B post-Q2 print). At our midpoint of $6.5B for FY26 and a ~$190 stock price, PLTR trades at roughly ~32x EV/sales on calendar 2026 — still richer than any large-cap software peer but the only enterprise software business growing 50%+ at this scale.

Guidance style: The "blowout-and-raise" cadence is now the expectation, set by Q2 and reinforced by Q3. The Q4 guide is itself aggressive (highest sequential ever); a typical "small beat-and-modest-raise" in February would be received as a deceleration. The bar is now extraordinarily high — which is the structural reason a perfectly clean print can still produce an 8% sell-off, as Q3 demonstrated.

Analyst Q&A Highlights

Topic: Sales-Cycle Compression & U.S. Commercial Sustainability

• Daniel Ives, Wedbush: Asked about the acceleration in sales cycles for boot-camp participants and the typical timeline from first contact to deal launch. Taylor cited the $1.3B U.S. Commercial TCV at 6x prior dollar-weighted duration; Karp framed the dynamic as a "private equity-like transformation" of customer unit economics.
  Assessment: The most informative answer of the call. The 6x duration multiple is the technical confirmation of structural deal-velocity change.

Topic: AIFDE / Internal AI Leverage and Government Programs

• Mariana Perez Mora, Bank of America: Asked about customer behavioral changes, internal AIFDE adoption, and U.S. government opportunities (Golden Dome, Maven, NGC2). Sankar contrasted +10% headcount growth with +63% revenue growth as the productivity proof point and noted the Army Vantage consolidation enables broader AIFDE adoption among uniformed personnel.
  Assessment: Confirmed AIFDE as both internal moat and external messaging asset. Government program color was incremental rather than revelatory; the Army Vantage progression is the most quantifiable item.

Topic: Europe / International

• Acknowledged Europe is "stagnant" with deliberate focus on U.S. commercial acceleration. No re-engagement plan disclosed.
  Notable non-answer: Three consecutive quarters of "deliberate deprioritization" framing without any timeline for reactivation is starting to read as a strategic gap rather than a sequencing choice.

Topic: Talent & Culture

• Karp emphasized "tribal culture preservation" and aversion to dilutive M&A; reiterated the "most important credential in tech" framing from Q2.
  Assessment: Talent retention story holds. The cultural posture is unchanged from Q2 but more explicit.

What They're NOT Saying

1. Still no FY26 preliminary framing. Identical pattern to Q2 — the magnitude of the FY25 raise would have permitted directional 2026 guidance, and the silence was specifically called out by sell-side commentary as a contributor to the Nov 4 sell-off. The market is now extrapolating its own FY26 numbers and the Q4 print becomes the definitive resolution.
2. No quantification of Army EA in-quarter contribution. The EA is presumed to have contributed to Q3 government revenue, but the dollar amount was not disclosed. We continue to model conservatively, but the lack of color leaves a wide modeling range.
3. No direct engagement with Microsoft Fabric / Databricks / Snowflake. Identical to Q2. As long as U.S. Commercial keeps printing +120% YoY, this is a non-issue; if growth ever normalizes, this question will move front and center.
4. No quantified AIFDE revenue contribution. AIFDE was elevated to central narrative but was not separately broken out as a revenue or bookings contributor. We do not know whether to model it as embedded in AIP or as a discrete revenue lever.
5. No update on international commercial restructuring. Three consecutive quarters of "deprioritization" framing without timeline is now a pattern. European competitors are taking long-cycle wins that Palantir is forfeiting.
6. No commentary on the dilution outlook. The buyback authorization at $880M remaining and SBC growing well below revenue both look favorable for dilution arithmetic, but management did not explicitly address share count trajectory or buyback pace given the elevated stock price.

Market Reaction

• Pre-print intraday high (Nov 3, Monday): $207.52 — an all-time intraday high reached in regular session before the AMC release.
• After-hours reaction (Nov 3, post-press release / call): Modestly negative; reports characterized AH trading as flat-to-down 2–3% as the magnitude of the beat was priced against the >$200 entry level.
• Intraday Nov 4 (Tuesday — cutoff): Sold off as much as ~16% intraday before recovering somewhat.
• T+1 close (Nov 4, Tuesday — cutoff): Closed down ~8% on the day; PLTR led tech declines despite the beat.
• T+1 volume: Elevated / heavy per multiple outlets (specific share count not consistently cited across sources).
• Estimated implied market cap at ~$190: ~$455B on ~2.4B diluted shares.
• Analyst reactions (within 24 hours): No major bracket downgrades reported; price targets generally raised or maintained, with commentary skewed cautious on valuation. Several sell-side notes referenced the "lack of company visibility for the whole of 2026" as a contributor to the cautious tone.

The print itself was the largest beat-and-raise of the cycle for Palantir, and yet the stock had its largest single-day sell-off since 2022. Two forces did the work: (1) the entry point (an all-time intraday high of $207.52 hit pre-print) created a buyer-exhaustion setup where even a perfect print could not extend the rally; (2) Michael Burry, posting on X for the first time after a 2-year hiatus, telegraphed a substantial put-options position against PLTR (and NVDA) framed as an "AI bubble" call. The combination of those two catalysts plus the absence of FY26 framing was sufficient to convert a 16% intraday sell-off into an 8% close. The fundamental print was unimpeachable; the market action was about positioning, not numbers.

Street Perspective

Debate: Has the Q3 Reacceleration Eliminated the Deceleration Risk?

Bull view: The acceleration from +93% (Q2) to +121% (Q3) at a higher base demonstrates that the deceleration math is being overwhelmed by the AIP land-and-expand motion. With $3.63B of U.S. Commercial RDV against $397M of in-quarter revenue (~9x coverage), and 21 deals over $10M just in the U.S. Commercial book this quarter, the trajectory is now mathematically supported through at least mid-2026 even on conservative conversion assumptions. The deceleration thesis is wrong.

Bear view: The reacceleration only delays the inevitable. By H2 2026, the comp set becomes punishing — you are trying to grow a quarterly U.S. Commercial book of ~$700M against a $397M comp at +121%. The math forces deceleration to ~60–80% by Q4 26 even on continued 30%+ sequential growth. The current multiple discounts none of that. The reacceleration is real but it is a delay, not a refutation.

Our take: Both sides are partly right. The reacceleration meaningfully derisks the next 2–3 quarters, which is the period the bears were targeting. But the deceleration math doesn't disappear — it gets pushed to mid-2026, when the comp set is genuinely brutal. Owning PLTR through the next two prints is a higher-conviction trade after this print; owning it on a 24-month view still requires belief that the +120% rate compounds against +200%+ comps.

Debate: Is the Operating Leverage Story Structural or Transient?

Bull view: The 51% adj operating margin against ~10% headcount growth is the proof point that Palantir is the first software company actually deploying AI on its own operations at scale. If durable, the structural margin ceiling moves from "high 40s" to "mid-to-high 50s" — several hundred bps of incremental fair-value support. Sankar's AIFDE framing is the technical mechanism; the P&L is the empirical evidence.

Bear view: One quarter is not a trend. The 500 bps margin beat could partly reflect timing of hiring slipping into Q4, deferred-comp accruals, or other one-time items not yet reconciled. The historical software-company pattern is that companies grow into their margin guides; structural margin breakouts of this magnitude rarely sustain without giving back some portion in the next 1–2 quarters.

Our take: One quarter is not enough to reset the long-term margin assumption. Two more quarters of margin expansion at low headcount growth would justify a structural reset of our model; one quarter justifies treating the productivity slope as a positive signal. We side cautiously with the bulls but require additional evidence before re-rating fair value on this dimension.

Debate: Does the Burry Short Matter for the Multi-Quarter Setup?

Bull view: Burry shorts have a mixed historical record (the early Tesla shorts being the most notable counterexample). The substance of the thesis — that PLTR is mathematically expensive — is not new and is already reflected in every sell-side bear note. The market clears around fundamentals, not headlines; with Q3 having printed +63% growth and a Rule of 40 of 114, the headline impact will be measured in days not quarters.

Bear view: The Burry name attached to a thesis that was already widely held is a sentiment catalyst with multi-week half-life. Combined with the fact that PLTR entered the print near an all-time high with retail and momentum positioning at the top of historical ranges, the catalyst can convert sentiment to flow in ways that fundamentals don't immediately offset. Look at the Nvidia after-print pattern from prior Burry calls for templates.

Our take: The fundamental impact is zero; the sentiment / positioning impact is real and probably persists for 2–6 weeks. For long-term holders, irrelevant. For tactical positioning into the Q4 print, the Burry catalyst keeps the "bad setup" risk elevated, which is one of the inputs into our continued Hold posture.

Debate: Is the Valuation Defensible — Updated for Q3?

Bull view: The Q3 print materially improves both the numerator (FY25 raised again, FY26 path more visible) and qualitative quality (operating leverage proof point) of the valuation argument. At ~32x our updated FY26 sales of $6.5B, PLTR is expensive but proportional to the Rule of 40 score. Best-in-class software businesses have historically traded at 18–25x sales; PLTR carries a premium for being the only one printing 50%+ growth at scale plus 50%+ adj operating margin. DCF math supports the current price under 25%+ FCF CAGR through 2030, which the trajectory now seems consistent with.

Bear view: ~32x forward sales and ~95x adj FCF guide on FY25 are still without precedent for any software business at any growth rate. Snowflake at peak 2021 traded at ~80x forward sales on +100% growth; PLTR's growth is half that and the sales multiple is not far below. The Q3 reacceleration improves the path but does not change the math — the valuation requires perfect execution through 2027 plus zero multiple compression as growth normalizes. The Burry note is the institutional articulation of what the math has long said.

Our take: Q3 made the operational case stronger and the valuation case marginally less stretched (helped by the 8% sell-off). But "less stretched" remains "stretched." Our view from Q2 stands: this is a great business at a price that requires you to be right about both the next 12 and the next 36 months of execution. The Q3 print made the next 12 months more bulletproof; the next 36 remain a stretch. We continue to want to own the business at a better entry point.

Model Implications

Updates to our model following Q3:

• FY25 revenue: Anchor at the high end of new guide ($4.40B). Our prior $4.155B model was below; we revise to $4.398B (+45% → +53% YoY). Q3 actual + Q4 guide implies the highest H2 ramp in company history.
• FY26 revenue: Revise to $6.4–6.7B from prior $5.75–5.90B (+38–42% → +45–50% YoY). U.S. Commercial assumed +90% YoY (deceleration from +104%+ FY25 implied), U.S. Government +35%, International blended +10–15%.
• Adjusted operating margin: FY25 raised to ~49% (per implied guide $2.153B / $4.398B). FY26 we revise upward to 50–52% from prior 47–48% — reflecting the Q3 productivity proof point but allowing for some give-back. Structural ceiling possibly 55%+ if the AIFDE leverage compounds.
• Adjusted FCF margin: FY25 ~46% (guide midpoint). FY26 model 48–50%.
• Stock-based compensation: Tracking modestly above prior expectations on absolute dollars ($0.7–0.75B FY25), but well below revenue growth, so SBC-as-% of revenue continues to compress.
• Diluted share count: 2.40–2.45B diluted; assume +1.5–2% annual growth net of $880M remaining buyback authorization. Buyback pace likely slows at $200+ price levels.
• Valuation framework: Sum-of-the-parts — U.S. Commercial moves to 22–26x forward sales (from 18–22x) reflecting the reacceleration; U.S. Government 9–11x; International blended 5–7x. Blended fair value ~16–19x forward sales. At ~$190 (~32x our FY26 estimate), PLTR remains 1.5–2 turns above our fair-value range.
• 12-month price target: Revised to $165 (range $130–$210) from prior $145. Below current price but reflects our valuation discipline. We would upgrade the rating before the price target on improved entry-point risk/reward (e.g., a drawdown to $140–150 without thesis impairment).

Thesis Scorecard Post-Earnings

Overall: Operating thesis decisively strengthened on every measurable dimension. We add a new bull point (AIFDE-driven structural margin leverage) requiring further confirmation. The valuation thesis remains the binding constraint, made temporarily more accommodating by the 8% sell-off but still demanding multi-year continued perfection.

Action: Maintaining Hold. Q3 made us more confident in owning the business but the entry point still needs to come to us. The Nov 4 sell-off is a step in that direction but not yet sufficient to upgrade. We would upgrade to Outperform on (a) a drawdown to $140–150 without thesis impairment (~25–30% from current levels), or (b) one additional quarter of evidence (the Q4 print, expected February 2026) confirming both the +120% U.S. Commercial trajectory durability and the structural margin step-up.